兴齐眼药：2025年上半年净利润3.35亿元，同比增长97.75%

Group 1 - The core viewpoint of the article highlights the strong financial performance of Xingqi Eye Pharmaceutical in the first half of 2025, with significant growth in both revenue and net profit [1] - The company achieved an operating income of 1.163 billion yuan, representing a year-on-year increase of 30.38% [1] - The net profit for the same period reached 335 million yuan, showing a remarkable year-on-year growth of 97.75% [1] - Basic earnings per share were reported at 1.36 yuan, indicating strong profitability [1] - The weighted average return on equity (ROE) stood at 19.16%, reflecting effective management and capital utilization [1]